Trade EBS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Emergent Biosolutions, Inc. (EBS) is trading at US$6.38, down 11.14% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$260.47M. Over the past 52 weeks, EBS has traded between US$4.36 and US$14.06. On Syfe you can trade EBS with $0 commission and add it to your watchlist.
| Previous close | US$7.18 |
|---|---|
| Market cap | US$260.47M |
| P/E ratio | 7.05 |
| 52-week range | US$4.36 – US$14.06 |
| Volume | 2.24M |
| Exchange | US |
Emergent Biosolutions, Inc.
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.
Year: 2006
Emergent BioSolutions Repurchases $75 Million of Senior Unsecured Notes Due 2028
Sep 3, 12:23 PM · MT Newswires
Emergent BioSolutions Wins $24 Million BARDA Contract for Anthrax Vaccine
Sep 1, 12:17 PM · MT Newswires
Emergent BioSolutions Awarded Standing Offer for Narcan Nasal Spray in Canada
Aug 31, 12:22 PM · MT Newswires
Sector Update: Healthcare Stocks Mixed Late Afternoon
Aug 6, 7:52 PM · MT Newswires
Emergent Biosolutions, Inc. (EBS) stock is trading at US$6.38, -11.14% from the previous close of US$7.18.
The market cap for Emergent Biosolutions, Inc. (EBS) stock is approximately US$260.47M.
The price-to-earnings ratio for Emergent Biosolutions, Inc. (EBS) is 7.05, based on the latest reported earnings.
The 52-week high for Emergent Biosolutions, Inc. (EBS) stock is US$14.06.
The 52-week low for Emergent Biosolutions, Inc. (EBS) stock is US$4.36.
Emergent Biosolutions, Inc. (EBS) does not currently pay a dividend.
Stay on top of EBS
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
